Brief: Double Bond Pharmaceutical Q3 Operating Loss Narrows To SEK 2.1 Mln
25/11/2019 06:50
Nov 25 (Reuters) - DOUBLE BOND PHARMACEUTICAL INTERNATIONAL
AB DBPHAb.TE :
* Q3 TOTAL REVENUE SEK 1.2 MLN VS SEK 0 YR AGO
* Q3 OPER LOSS SEK 2.1 MLN VS LOSS SEK 2.3 MLN YR AGO
Source text for Eikon: urn:newsml:reuters.com:*:nWkrc3RJFn
Further company coverage: DBPHAb.TE
(Gdansk Newsroom)
((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10))
Recent news on Double Bond Pharmaceutical International AB (publ)
See all newsBrief: DBP International AB And Vivo Biopharma LLC Revised Asset Purchase And Collaboration Agreements
Brief: DBP International AB And Vivo Biopharma LLC Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: DBP And Vivo Enter Into Asset Purchase And Collaboration Agreements To Develop And Commercialize A Novel Glioblastoma Treatment
Brief: Double Bond Pharmaceutical Says Positive Response For SI-053 From Ethical Committee In Netherlands Has Been Received
Brief: Double Bond To Cooperate With Belarus State Medical University